Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q2254797> ?p ?o }
Showing triples 1 to 48 of
48
with 100 triples per page.
- Q2254797 subject Q8248726.
- Q2254797 subject Q8617683.
- Q2254797 abstract "Nateglinide (INN, trade name Starlix) is a drug for the treatment of type 2 diabetes. Nateglinide was developed by Ajinomoto, a Japanese company and sold by the Swiss pharmaceutical company Novartis.Nateglinide belongs to the meglitinide class of blood glucose-lowering drugs.".
- Q2254797 atcPrefix "A10".
- Q2254797 atcSuffix "BX03".
- Q2254797 casNumber "105816-04-4".
- Q2254797 chEBI "31897".
- Q2254797 drugbank "DB00731".
- Q2254797 fdaUniiCode "41X3PWK4O2".
- Q2254797 iupacName "(2R)-2-({[trans-4-(1-methylethyl)cyclohexyl]carbonyl}amino)-3-phenylpropanoic acid".
- Q2254797 pubchem "60026".
- Q2254797 thumbnail Nateglinide.svg?width=300.
- Q2254797 wikiPageExternalLink index.jsp.
- Q2254797 wikiPageExternalLink howitworks.jsp.
- Q2254797 wikiPageWikiLink Q1767180.
- Q2254797 wikiPageWikiLink Q21163221.
- Q2254797 wikiPageWikiLink Q2195995.
- Q2254797 wikiPageWikiLink Q3025883.
- Q2254797 wikiPageWikiLink Q412826.
- Q2254797 wikiPageWikiLink Q412926.
- Q2254797 wikiPageWikiLink Q423778.
- Q2254797 wikiPageWikiLink Q507154.
- Q2254797 wikiPageWikiLink Q5958765.
- Q2254797 wikiPageWikiLink Q80863.
- Q2254797 wikiPageWikiLink Q818846.
- Q2254797 wikiPageWikiLink Q824258.
- Q2254797 wikiPageWikiLink Q8248726.
- Q2254797 wikiPageWikiLink Q8386.
- Q2254797 wikiPageWikiLink Q841822.
- Q2254797 wikiPageWikiLink Q8617683.
- Q2254797 wikiPageWikiLink Q877827.
- Q2254797 wikiPageWikiLink Q9618.
- Q2254797 atcPrefix "A10".
- Q2254797 atcSuffix "BX03".
- Q2254797 casNumber "105816".
- Q2254797 chebi "31897".
- Q2254797 drugbank "DB00731".
- Q2254797 iupacName "-2".
- Q2254797 pubchem "60026".
- Q2254797 unii "41".
- Q2254797 type ChemicalSubstance.
- Q2254797 type Drug.
- Q2254797 type ChemicalObject.
- Q2254797 type Thing.
- Q2254797 type Q8386.
- Q2254797 comment "Nateglinide (INN, trade name Starlix) is a drug for the treatment of type 2 diabetes. Nateglinide was developed by Ajinomoto, a Japanese company and sold by the Swiss pharmaceutical company Novartis.Nateglinide belongs to the meglitinide class of blood glucose-lowering drugs.".
- Q2254797 label "Nateglinide".
- Q2254797 depiction Nateglinide.svg.